White House Unveils Long-Awaited Public Access Policy
By Jocelyn Kaiser,
Science Insider
| 02. 22. 2013
In a victory for open access advocates, the White House science office today released a long-awaited policy aimed at sharing the results of federally funded research with the public. The policy will require that science agencies make papers that they fund freely available online within 12 months after the results appear in a journal.
The policy follows several years of consultations and a
petition to the White House from open access advocates last year. It appears to have found a middle ground between the two sides in a decadelong debate over so-called "open access"—the issue of whether and when scientific papers funded with taxpayer dollars should be available, for free, to the public. Traditionally, publicly funded scientists have published their work in scholarly journals that charge fees for access to the papers. That system has broken down in recent years, however, with the advent of digital technologies and new research funding models. Many journals and scientific societies have resisted complete and immediate open access, arguing that it will destroy the revenue streams they need to survive.
The new federal directive...
Related Articles
By Julia Black and Margaux MacColl, The Information [cites CGS' Katie Hasson] | 07.19.2024
When venture capitalist Jack Abraham first began dating his wife, Gabriella Massamillo, he insisted on one condition: that when they were ready to have children, she’d be willing to conceive using in vitro fertilization. Abraham had lost both his mother...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Peter Aldhous, Scientific American | 07.02.2024
In June a notice posted on the website of the journal Nature set a new scientific record. It withdrew what is now the most highly cited research paper ever to be retracted.
The study, published in 2002 by Catherine Verfaillie...
By Emma McDonald Kennedy
| 07.11.2024
Louise Perry’s recent article in The Spectator cautions against “The quiet return of eugenics,” a threat she locates in preimplantation genetic testing for polygenic disorders. The technology is billed as a way for parents undergoing IVF to select which embryo to implant based on information about each embryo’s genetic risk factors and traits. These reports, she says, give parents “a very full picture of the adult that embryo could become”––from their child’s risk of developing different diseases to their “likely...